** Shares of drugmaker Perrigo PRGO.N rise 20% to $28.98, highest in about three months
** Co says on an investor call that it will lay out plans to "consumerize, simplify and scale its global self-care platform"
** Expects 2025 adj profit of $2.90 to $3.10 per share, compared to analysts' estimate of $3.04 per share
** Sees 2025 net sales growth of 1% to 3%; organic compound annual sales growth of 2.5% to 4.5% for 2025 to 2027
** Co posted late on Thursday Q4 sales of $1.14 bln compared to analysts' estimate of $1.2 bln, according to data compiled by LSEG
** Co reported Q4 adj profit of 93 cents per share in line with estimates
** PRGO has fallen 25% in the last 12 months
(Reporting by Siddhi Mahatole)
((siddhi.mahatole@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。